Page 150 - Molecular features of low-grade developmental brain tumours

5
148
CHAPTER 5
71. Ramachandran, R. K., Sorensen, M. D., Aaberg-Jessen, C., Hermansen, S. K. & Kristensen, B. W. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas. PLoS One 12, e0172234, doi:10.1371/journal.pone.0172234 (2017).
72. Wang, L. et al. Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma. Clin Transl Oncol 15, 139-145, doi:10.1007/s12094-012-0900-5 (2013).
73. Thorns, V., Walter, G. F. & Thorns, C. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 23, 3937-3944 (2003).
74. Stojic, J. et al. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60, 40-49, doi:10.1016/j. neures.2007.09.009 (2008).
75. Kachra, Z. et al. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis 17, 555-566 (1999).
76. Atkinson, S. J. et al. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 270, 30479-30485, doi:10.1074/jbc.270.51.30479 (1995).
77. Itoh, Y. et al. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20, 4782-4793, doi:10.1093/emboj/20.17.4782 (2001).
78. Lettau, I. et al. Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells. J Neuropathol Exp Neurol 69, 215-223, doi:10.1097/NEN.0b013e3181ce9f67 (2010).
79. Korotkov, A. et al. Increased expression of matrix metalloproteinase 3 can be attenuated by inhibition of microRNA-155 in cultured human astrocytes. J Neuroinflammation 15, 211, doi:10.1186/ s12974-018-1245-y (2018).